Clinical Trial Update: Sildenafil for PNTM Infection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Sildenafil in nontuberculous mycobacterial infection (Phase 1/2); the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nontuberculous Mycobacterial Infection

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Nontuberculous Mycobacterial Infection | Phase 1, Phase 2 | Status: COMPLETED